Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 276,935 | 301,320 | 294,146 | 271,581 | 269,655 |
| Cost of Goods | 91,744 | 96,622 | 91,984 | 88,221 | 90,060 |
| Gross Profit | 185,191 | 204,698 | 202,162 | 183,360 | 179,595 |
| Operating Expenses | 130,073 | 110,795 | 122,935 | 115,690 | 123,338 |
| Operating Income | 55,862 | 94,525 | 80,211 | 67,891 | 56,317 |
| Other Income | -6,304 | -6,207 | -15 | -1,462 | 47,399 |
| Pre-tax Income | 49,558 | 88,318 | 80,196 | 66,429 | 103,716 |
| Income Tax | -1,435 | 12,833 | 9,978 | 16,424 | 13,982 |
| Net Income Continuous | 50,993 | 75,485 | 70,218 | 50,005 | 89,734 |
| Minority Interests | N/A | N/A | 0 | N/A | 179 |
| Net Income | $50,993 | $75,485 | $70,218 | $50,005 | $89,555 |
| EPS Basic Total Ops | 0.32 | 0.47 | 0.45 | 0.32 | 0.57 |
| EPS Basic Continuous Ops | 0.32 | 0.48 | 0.45 | 0.32 | 0.57 |
| EPS Diluted Total Ops | 0.31 | 0.47 | 0.43 | 0.31 | 0.55 |
| EPS Diluted Continuous Ops | 0.31 | 0.47 | 0.43 | 0.31 | 0.55 |
| EBITDA(a) | $84,402 | $121,448 | $107,182 | $94,594 | $82,958 |